Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway

Clinical Cancer Research

Volumn 11, Issue 3, 2005, Pages 1050-1058

  Sun, Bailong ^a   Nishihira, Jun ^a,b   Yoshiki, Takashi ^b   Kondo, Masao ^a   Sato, Yuji ^a   Sasaki, Fumiaki ^a   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GeneticLab Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; FOCAL ADHESION KINASE; LYSOPHOSPHATIDIC ACID; MACROPHAGE MIGRATION INHIBITION FACTOR; MATRIGEL; MESSENGER RNA; RHO FACTOR; SMALL INTERFERING RNA; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; IN VIVO STUDY; KNOCKOUT GENE; LIVER METASTASIS; MACROPHAGE; MACROPHAGE MIGRATION INHIBITION; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSOPHOSPHOLIPIDS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROTEIN-SERINE-THREONINE KINASES; RHO GTP-BINDING PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 12944288173     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. David JR. Delayed hypersensitivity in vitro: its mediation by cell free substances forms by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 1966;56:72-7.
2. Bloom BR, Bennettm B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80-2.
3. Bucala R. MIF re-discovered: pituitary hormone and glucocorticoid-induced regulator of cytokine production. FASEB J 1996;7:19-24.
4. Nishihira J. Macrophage migration inhibitory factor (MIF): Its essential role in the immune system and cell growth. J Interferon Cytokine Res 2000;20:751-62.
5. Bernhagen J, Calandra T, Mitchel RA, et al. MIF is the pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-9.
6. Calandra T, Bernhagen J, Mitchell RA, Mitchell J, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895-902.
7. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996;93:7849-54.
8. Calandra T, Bernhagen J, Mets CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
9. Meyer-Siegler K, Hudson PB. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology 1996;48:448-52.
10. Sun B, Nishihira J, Suzuki M, et al. Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis. Int J Mol Med 2003;12:633-41.
11. Horwitz AR, Parsons JT. Cell migration: movin' on. Science 1999;286:1102-3.
12. Chrzanowska-Wodnicka M, Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 1996;133:1403-15.
13. Shida D, Kitayama J, Yamaguchi H, et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 2003;63:1706-11.
14. Goetzl EJ, An S. Diversity of cellular receptors and functions for the lysophosphatidic acid and sphingosine 1-phosphate. FASEB J 1998;12:1589-98.
15. Sawada K, Morishige KI, Tahara M, et al. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells. Gynecol Oncol 2002;87:252-9.
16. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
17. Nishihira J, Kuriyama T, Sakai M, Nishi S, Ohki S, Hikichi K. The structure and physicochemical properties of rat liver macrophage migration inhibitory factor. Biochim Biophys Acta 1995;1247:159-62.
18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4.
19. Schagger H, Von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368-79.
20. Lanahan A, Williams JB, Sanders LK, Nathans D. Growth factor-induced delayed early response genes. Mol Cell Biol 1992;12:3919-29.
21. Bini L, Magi B, Marzocchi B, et al. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 1997;18:2832-41.
22. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1999;5:181-91.
23. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun 1999;264:751-8.
24. Ogawa H, Nishihira J, Sato Y, et al. An antibody for macrophage migration inhibitory factor suppresses tumor growth and inhibits tumor-associated angiogenesis. Cytokine 2000;12:309-14.
25. Hamilton A, Baulcombe D. A species of small antisense RNA in post-transcriptional gene silencing in plants. Science 1999;286:950-2.
26. Peterson HF, Self AJ, Carrett MD, Just I, Aktories K, Hall A. Microinjection of recombinant P21 rho induces rapid changes in cell morphology. J Cell Biol 1990;111:1001-7.
27. Takaishi K, Kikuchi A, Kuroda S, Kotani K, Sasaki T, Takai Y. Involvement of rho P21 and its inhibitory GDP/GTP exchange in cell morphology. J Cell Biol 1993;13:72-9.
28. Yoshioka K, Matsumura F, Akedo H, Itoh K. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J Biol Chem 1998;273:5146-54.
29. Guan JL, Shalloway D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 1992;358:690-2.
30. Hanks SK, Calalb MB, Harper MC, Patel SK. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachement to fibronectin. Proc Natl Acad Sci U S A 1992;89:8487-91.
31. Schallar MD, Borgman CA, Cobb BS, Vines RJB, Reynolds AB, Parsons JT. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A 1992;89:5192-6.
32. Mukai M, Togawa A, Imamura F, et al. Sustained tyrosine-phosphorylation of FAK through Rho-dependent adhesion to fibronectin is essential for cancer cell migration. Anticancer Res 2002;22:3175-84.
33. Chrzanowska-Wodnicka M, Burridge, K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 1996;133:1403-15.
34. Wang JH, Manning BJ, Wu QD, Blankson S, Bouchier-Hayes D, Redmond HP. Endotoxin/lipopolysaccharide activates NF-κB and enhances tumor cell adhesion and invasion through a β1 integrin-dependent mechanism. J Immunol 2003;170:795-804.
35. Ren XD, Kiosses WB, Sieg DJ, Otey CA, Schlaepfer DD, Schwartz MA. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci 2000;113:3673-8.
36. Fishman DA, Liu Y, Ellerbroek SM, Stack MS. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res 2001;61:3194-9.
37. Ohnishi Y, Sakamoto T, Fujii H, et al. Characterization of a liver metastatic variant of murine colon 26 carcinoma cells. Tumor Biol 1997;18:113-22.
38. Tigyi G, Miledi R. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J Biol Chem 1992;267:21360-7.
39. Sawada K, Morishige K, Tahara M, et al. Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62:6015-20.